Hepatitis Monthly Hepatitis Monthly Hepat Mon http://www.hepatmon.portal.tools 1735-143X 1735-3408 10.5812/hepatmon en jalali 2019 11 15 gregorian 2019 11 15 13 11
en 10.5812/hepatmon.16082 Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013 Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013 meeting-report meeting-report

The cross-border symposium on hepatitis C, entitled “why treating now?” was held on 15th May 2013 during the 5th International Tehran Hepatitis Congress. The present report summarizing communicated insights during this symposium is intended to help health care providers to make well-informed decisions when treating patients with chronic hepatitis C (CHC). Since today’s evolving science of hepatitis C management has introduced new treatment options, one should be well-versed about the potential benefits as well as untoward effects or practical challenges when using these regimens. In addition to outline HCV treatment advances, this symposium focused on the central question that why eligible patients with hepatitis C who may mostly benefit from the currently available protease inhibitors, should be treated now rather than be waited for the future therapies. Moreover, an overview of long term local experience with protease inhibitors in our challenging hepatitis C patients was presented during this interactive symposium.

The cross-border symposium on hepatitis C, entitled “why treating now?” was held on 15th May 2013 during the 5th International Tehran Hepatitis Congress. The present report summarizing communicated insights during this symposium is intended to help health care providers to make well-informed decisions when treating patients with chronic hepatitis C (CHC). Since today’s evolving science of hepatitis C management has introduced new treatment options, one should be well-versed about the potential benefits as well as untoward effects or practical challenges when using these regimens. In addition to outline HCV treatment advances, this symposium focused on the central question that why eligible patients with hepatitis C who may mostly benefit from the currently available protease inhibitors, should be treated now rather than be waited for the future therapies. Moreover, an overview of long term local experience with protease inhibitors in our challenging hepatitis C patients was presented during this interactive symposium.

Hepatitis C;Protease Inhibitors;Management;Iran Hepatitis C;Protease Inhibitors;Management;Iran http://www.hepatmon.portal.tools/index.php?page=article&article_id=16082 Nasser Ebrahimi Daryani Nasser Ebrahimi Daryani Department of Gastroenterology and Hepatology, Tehran University of Medical Sciences, Tehran, IR Iran Department of Gastroenterology and Hepatology, Tehran University of Medical Sciences, Tehran, IR Iran Seyed Moayed Alavian Seyed Moayed Alavian Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, IR Iran; Middle East Liver Disease Center (MELD), Tehran, IR Iran; Baqiyatallah University of Medical Sciences, Tehran, IR Iran. Tel: +98-2188945187, Fax: +98-2188945186 Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, IR Iran; Middle East Liver Disease Center (MELD), Tehran, IR Iran; Baqiyatallah University of Medical Sciences, Tehran, IR Iran. Tel: +98-2188945187, Fax: +98-2188945186 Mohammad Hossein Somi Mohammad Hossein Somi Research Center for Gastroenterology and Liver Disease, Tabriz University of Medical Sciences, Tabriz, IR Iran Research Center for Gastroenterology and Liver Disease, Tabriz University of Medical Sciences, Tabriz, IR Iran Mohammad Torabi-Nami Mohammad Torabi-Nami School of Advanced Medical Science and Technologies, Shiraz University of Medical Sciences, Shiraz, IR Iran School of Advanced Medical Science and Technologies, Shiraz University of Medical Sciences, Shiraz, IR Iran